menu search

Cassava sciences: my bullish take on biomarkers and ctad data

Cassava Sciences' stock is highly disputed due to conflicting opinions on the science behind its drug candidate, but outside research supports its app...

October 30, 2023, 3:30 am

Moderna and caris life sciences partner to develop mrna oncology therapeutics

Moderna Therapeutics Inc (NASDAQ:MRNA) has teamed up with Texas-headquartered private precision medicine and molecular science firm Caris Life Science...

October 24, 2023, 10:21 am

Labcorp launches 3-part blood test for alzheimer's

Labcorp on Wednesday began marketing to U.S. physicians the first test for a trio of blood biomarkers i...

October 11, 2023, 7:34 am

Renalytix sinks to near year low despite news of strengthening us patents

Renalytix PLC (AIM:RENX) shares fell 12% to 46.09p after it said newly allowed US patents further strengthen the core intellectual property underpi...

October 6, 2023, 4:26 am

Mainz biomed to present detailed results of colofuture study at international conference on gastroenterology

Clinical trial evaluating the Company's novel mRNA biomarkers demonstrated sensitivity for colorectal c...

September 27, 2023, 8:01 am

Circular genomics announces partnership on alzheimer’s disease biomarker research

Albuquerque, NM, Sept. 06, 2023 (GLOBE NEWSWIRE) — Circular Genomics, the global leader in circular RNA biom...

September 6, 2023, 9:24 pm

Cardiac biomarkers market to accelerate at a cagr of 11%, reaching us$ 38 billion by 2033: fact.mr report

Rising cases of myocardial infarction and acute coronary syndrome are leading to the increasing demand for cardiac ...

August 17, 2023, 7:00 am

Mps ii and beyond: implications of denali's promising pipeline

Denali Therapeutics is a promising underdog in the biotech sector, focusing on neurodegenerative diseases, with significant investments in scientific ...

July 23, 2023, 12:51 am

Retinalgenix technologies, inc. nears completion of institutional review board for research on dna/gps program

Study Intends To Identify Hematology biomarkers That May Help Personalize Medical Evaluations For Patie...

June 26, 2023, 10:15 am

Uniqure (qure) falls on mixed huntington's disease study results

uniQure (QURE) stock declines after the company announces mixed results from its biomarkers analysis in...

June 22, 2023, 11:51 am

Sera prognostics: buy the pretrm moat

Sera Prognostics is a promising company with a mission to improve pregnancy outcomes through its blood test product, PreTRM, which identifies ...

June 8, 2023, 6:58 pm

Intercept (icpt) announces positive data from pbc study

Intercept Pharmaceuticals (ICPT) announces new data showing the potential of a fixed-dose combination of OCA and bezafibrate to normalize multiple ...

June 7, 2023, 3:49 pm

Here's why hepion pharma (hepa) is up more than 80% in two days

Hepion Pharmaceuticals' (HEPA) lead pipeline candidate, rencofilstat, demonstrates improvements in physiologic liver function and key NASH ...

May 24, 2023, 1:13 pm

Hepion pharmaceuticals’ phase 2 ‘altitude-nash’ trial achieves primary and secondary endpoints, including improvement in liver function and multiple nash biomarkers

– Improvements in physiologic liver function and key NASH biomarkers including ALT, ProC3, PIIINP and...

May 22, 2023, 11:00 am

Thermo fisher (tmo) gets fda clearance for its immunoassays

Thermo Fisher (TMO) announces the FDA clearance of its blood-based biomarkers used in the determination...

May 22, 2023, 9:04 am

Jounce therapeutics announces closing of tender offer

Stockholders to Receive $1.85 Per Share in Cash Plus Contingent Value Rights CAMBRIDGE, Mass., May 03, 2023 (GLOBE NEWSWIRE) — Jounce Therapeutics, ...

May 4, 2023, 12:35 am

Aclarion to host thought leadership symposium at spineweek 2023

Nociscan™ is the first evidence-supported SaaS platform to objectively measure discogenic biomarkers ...

April 28, 2023, 3:20 pm

Aclarion skyrockets on positive trial data for lower back pain intelligence platform

Aclarion shares skyrocketed after the company published data from a two-year trial that demonstrated improved surgical outcomes for discogenic lower b...

April 24, 2023, 11:46 am

The global digital breast tomosynthesis (dbt) system market size is expected to grow from usd us$ 8.1 billion in 2023 to 2030. at a cagr of 14.2% during forecast period 2023 to 2030 | data by contrive

According to a market research study published by Contrive Datum Insights, Liquid biopsy is a non-invasive diagnostic tool that involves the analysis ...

April 18, 2023, 12:38 am

The global digital breast tomosynthesis (dbt) system market size is expected to grow from usd us$ 8.1 billion in 2023 to 2030. at a cagr of 14.2% during forecast period 2023 to 2030 | data by contrive

According to a market research study published by Contrive Datum Insights, Liquid biopsy is a non-invasive diagnostic tool that involves the analysis ...

April 18, 2023, 12:38 am


Search within

Pages Search Results: